N/A
Completed N=64
Cognitive-behavioral Therapy for Generalized Anxiety Disorder in Primary Care
Source: ClinicalTrials.gov NCT03621371 ↗Enrolled (actual)
64
Serious AEs
—
Results posted
Jan 2025
Primary outcomePrimary: Penn State Worry Questionnaire - Measure of Symptom Change — 42.1; 55.8 score on a scale — p=<0.05
Summary
The feasibilty and preliminary comparative effectiveness of two methods of cognitive-behavioral therapy - metacognitive therapy and intolerance of uncertainty therapy - for primary care patients with generalized anxiety disorder is investigated in a pilot study using a randomized controlled design. Purpose of the study is to examine the feasibility of a full-scale randomized controlled trial. Research questions primarily concern recruitment, measurement, and adherence.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Penn State Worry Questionnaire - Measure of Symptom Change |
42.1; 55.8 | <0.05 sig |
Eligibility Criteria
Inclusion Criteria
- Primary diagnosis of generalized anxiety disorder
- Age 18 years or above
- Being able to understand and speak Swedish without interpreter support
Exclusion Criteria
- Psychosis, bipolar disorder, severe depressive symptoms, risk of suicid, substance use disorder, intellectual disability
- Simultaneous psychological treatment
- If pharmacological treatment, it needs to be stable prior to and during treatment
Data sourced from ClinicalTrials.gov (NCT03621371). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.